← Back to ANIK

Anika Therapeutics Inc. - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 29/07/2026Mar 2026Filed 29/07/2026Sep 2025Filed 05/11/2025Jun 2025Filed 29/07/2026Mar 2025Filed 29/07/2026Sep 2024Filed 05/11/2025Jun 2024Filed 05/11/2025Mar 2024Filed 05/11/2025
$33$30$28$28$26$30$31$29
$3.3−$5.1−$2.3−$4−$4.9−$30−$0.1−$4.5
$0.24−$0.37−$0.16−$0.28−$0.34−$2.03$0.00−$0.31
1414141514151515

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.